American Financial: 3 Key Takeaways for Long-Term Investors

American Financial reported record third-quarter 2026 core net operating earnings per share, up 48% year over year, and declared a special cash dividend of $3.50 per share. The insurer invested approximately $1.5 billion in fixed maturities during the quarter as yields approached 6%, while management said renewal rates have increased for 41 consecutive quarters. Management expects significant excess capital through the rest of 2026 and into 2027, supporting potential acquisitions, special dividends or share repurchases.

Analysis

The key underwriting question is whether earnings strength survives without the contribution from asset sales. Treat the 48% EPS increase as lower-quality until AFG discloses recurring operating earnings excluding realized gains and confirms loss-cost trends remain below renewal pricing. The 41-quarter pricing streak is valuable only while rate increases exceed claims inflation; social inflation and legal severity can erase that spread with a lag.

The $1.5 billion bond deployment should lift investment income progressively as cash is reinvested, not immediately across the portfolio. It also increases exposure to duration and mark-to-market losses if yields rise further. Higher rates are therefore a medium-term earnings tailwind but a potential near-term book-value headwind. California exposure cuts may protect margins, while shifting business to competitors; the less visible risk is that reduced volume limits diversification or leaves AFG with a less favorable residual book.

Near term, the special dividend is a capital-return catalyst, but not evidence of a higher recurring payout. Over 1–3 months, focus on underlying underwriting results and capital-allocation follow-through. Over 6–18 months, the thesis depends on pricing staying ahead of loss costs as commercial lines eventually soften. The optimistic framing may underweight earnings quality and reserve uncertainty; no valuation or consensus data are provided to establish that the shares are mispriced.

Key Decisions for Investors

• Keep AFG on a conditional long/watchlist rather than chase the reported EPS growth. Reassess after verifying recurring earnings excluding asset-sale gains, combined ratio, and reserve development.
• For a 1–3 month catalyst, monitor the special-dividend record/ex-payment dates and any repurchase or acquisition updates. Do not treat the cash distribution as recurring earnings; account for the mechanical ex-dividend price adjustment.
• Track renewal pricing against claim-cost trends and California exposure changes. A narrowing rate-versus-loss-cost spread, adverse reserve development, or deterioration in the combined ratio would falsify the underwriting thesis and warrant reducing exposure.
• Monitor investment income alongside fixed-income portfolio duration and unrealized losses. Further yield increases may benefit reinvestment income over time but could pressure book value first; verify the portfolio disclosures before sizing a rates-sensitive position.